RT Journal Article
SR Electronic
T1 Epidemics, Air Travel, and Elimination in a Globalized World: The Case of Measles
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.08.20095414
DO 10.1101/2020.05.08.20095414
A1 Shaun Truelove
A1 Luis Mier-y-Teran-Romero
A1 Paul Gastanaduy
A1 Allison Taylor Walker
A1 Andre Berro
A1 Justin Lessler
A1 Michael A. Johansson
YR 2020
UL http://medrxiv.org/content/early/2020/05/12/2020.05.08.20095414.abstract
AB Although the United States (U.S.) declared measles eliminated in 2000, so long as measles circulates globally, continued importations will trigger sporadic U.S. outbreaks. The United States is highly connected to the rest of the world, and importations occur largely as a result of air travel by U.S. residents and international visitors. We developed a model to assess the risk of measles virus importation from Europe, Asia, and Africa through air travel. We projected 308 (95% prediction interval, 151-518) total measles cases imported from 66 countries during 2006-2015; 290 importations were reported. The model projected a spike in importation risk from Israel during October 2018, coincident with large, importation-triggered outbreaks in New York and New Jersey. Our model shows U.S. importation risk primarily originates from European and Asian countries. Models such as this inform preemptive actions to mitigate infectious disease threats, but only if we prioritize global surveillance and data sharing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Bill & Melinda Gated Foundation [S.A.T. and J.L., grant OPP1094793].Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThese analyses require three primary sources of data: reported measles cases from source locations, travel volume data, and population data. Reported monthly measles cases are available publicly from the World Health Organization (https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/). Population data are publicly available from the United Nations World Population Prospects data (https://population.un.org/wpp/). Monthly air travel are primarily from OAG (OAG Aviation Worldwide, https://www.oag.com/). These data were provided under contract and cannot be provided by the authors. Additionally, data on reported measles importation were used for validation. These data were provided by the U.S. Centers for Disease Control and Prevention and are not currently available to the public.